Related Experiment Video
Updated: Aug 30, 2025

09:17
Using Retinal Imaging to Study Dementia
Published on: November 6, 2017
21.7K
Glucometabolic Changes Are Associated with Structural Gray Matter Alterations in Prodromal Dementia
Mélissa Gentreau1, Christelle Reynes1, Robert Sabatier1
1IGF, University of Montpellier, CNRS, INSERM, Montpellier, France.
Journal of Alzheimer'S Disease : JAD
|August 29, 2022
Summary
A high glycemic load (GL) diet and insulin resistance (IR) are linked to reduced gray matter volume in brain areas critical for Alzheimer's disease (AD) pathology.
Area of Science:
- Neuroscience
- Metabolic Health
- Neurodegenerative Diseases
Background:
- High glycemic load (GL) diets and insulin resistance (IR) are implicated as risk factors for Alzheimer's disease (AD).
- The specific impact of these glucometabolic factors on brain structural changes relevant to AD pathology remains unclear.
Purpose of the Study:
- To investigate the association between GL and IR with gray matter volumes in brain regions associated with prodromal dementia.
- To determine if metabolic factors influence brain structures vulnerable in early stages of cognitive decline.
Main Methods:
- Calculated GL and the Triglyceride-Glucose (TyG) index (a marker for IR) in 497 participants.
- Utilized magnetic resonance imaging (MRI) to assess gray matter volumes.
- Employed a machine learning algorithm to identify brain regions linked to mild cognitive impairment (MCI) over a 7-year follow-up.
Main Results:
- Higher GL was significantly associated with reduced amygdala volume.
- The TyG index showed negative correlations with volumes of the hippocampus, amygdala, and putamen.
- These brain regions are critical for memory and emotion processing, often affected in early dementia.
Conclusions:
- Elevated GL and IR are associated with diminished gray matter volumes in key brain areas relevant to Alzheimer's disease.
- These findings highlight the potential role of metabolic dysregulation in driving structural brain changes preceding dementia.
- Further research is warranted to explore therapeutic strategies targeting GL and IR to preserve brain structure and function.
Keywords:
Amygdaladementiaglycemic loadhippocampusinsulin resistancemagnetic resonance imagingputamenMore Related Videos
Related Concept Videos
Alzheimer's Disease: Overview
650
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
650
Dementia
159
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
159

